Your browser doesn't support javascript.
loading
Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study.
Willame, C; Dodd, C; Durán, C E; Elbers, Rjhj; Gini, R; Bartolini, C; Paoletti, O; Wang, L; Ehrenstein, V; Kahlert, J; Haug, U; Schink, T; Diez-Domingo, J; Mira-Iglesias, A; Carreras, J J; Vergara-Hernández, C; Giaquinto, C; Barbieri, E; Stona, L; Huerta, C; Martín-Pérez, M; García-Poza, P; de Burgos, A; Martínez-González, M; Bryant, V; Villalobos, F; Pallejà-Millán, M; Aragón, M; Carreras, J J; Souverein, P; Thurin, N H; Weibel, D; Klungel, O H; Sturkenboom, McJm.
  • Willame C; Department of Datascience & Biostatistics, University Medical Center Utrecht, Heidelberglaan 100, the Netherlands. Electronic address: c.willame@umcutrecht.nl.
  • Dodd C; Department of Datascience & Biostatistics, University Medical Center Utrecht, Heidelberglaan 100, the Netherlands. Electronic address: caitlinndodd@gmail.com.
  • Durán CE; Department of Datascience & Biostatistics, University Medical Center Utrecht, Heidelberglaan 100, the Netherlands. Electronic address: c.e.duransalinas@umcutrecht.nl.
  • Elbers R; Department of Data science & Biostatistic, Data manegement, University Medical Center Utrecht, Heidelberglaan 100, the Netherlands. Electronic address: r.j.h.elbers@umcutrecht.nl.
  • Gini R; Agenzia regionale di sanità della Toscana, via Pietro Dazzi 1, 55100 Florence, Italy. Electronic address: rosa.gini@ars.toscana.it.
  • Bartolini C; Agenzia regionale di sanità della Toscana, via Pietro Dazzi 1, 55100 Florence, Italy. Electronic address: claudia.bartolini@ars.toscana.it.
  • Paoletti O; Agenzia regionale di sanità della Toscana, via Pietro Dazzi 1, 55100 Florence, Italy. Electronic address: olga.paoletti@ars.toscana.it.
  • Wang L; Department of Clinical Epidemiology, Aarhus University Hospital, Denmark. Electronic address: lei.wang@clin.au.dk.
  • Ehrenstein V; Department of Clinical Epidemiology, Aarhus University Hospital, Denmark. Electronic address: ve@clin.au.dk.
  • Kahlert J; Department of Clinical Epidemiology, Aarhus University Hospital, Denmark. Electronic address: jok@clin.au.dk.
  • Haug U; Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Faculty of Human and Health Sciences, University of Bremen, Germany. Electronic address: haug@leibniz-bips.de.
  • Schink T; Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology - BIPS, 28359 Bremen, Germany. Electronic address: schink@leibniz-bips.de.
  • Diez-Domingo J; Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain. Electronic address: Javier.Diez@fisabio.es.
  • Mira-Iglesias A; Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain. Electronic address: Ainara.Mira@fisabio.es.
  • Carreras JJ; Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain. Electronic address: Juanjo.Carreras@fisabio.es.
  • Vergara-Hernández C; Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain. Electronic address: Vergara_car@gva.es.
  • Giaquinto C; Division of Paediatric Infectious Diseases, Department of Women's and Children's Health, University of Padova, Padova, Italy. Electronic address: carlo.giaquinto@unipd.it.
  • Barbieri E; Division of Paediatric Infectious Diseases, Department of Women's and Children's Health, University of Padova, Padova, Italy. Electronic address: elisa.barbieri@unipd.it.
  • Stona L; Fondazione Penta ONLUS, Corso Stati Uniti 4, 35127 Padova, Italy. Electronic address: luca.stona@pentafoundation.org.
  • Huerta C; Department of Public Health and Maternal and Child Health, Faculty of Medicine, Complutense University of Madrid, 28040 Madrid, Spain. Electronic address: mahuer05@ucm.es.
  • Martín-Pérez M; Pharmacoepidemiology and Pharmacovigilance Division, Medicines for Human Use Department, Spanish Agency for Medicines and Medical Devices (AEMPS), Calle Campezo 1, 28022 Madrid, Spain. Electronic address: mmmartinp@aemps.es.
  • García-Poza P; Pharmacoepidemiology and Pharmacovigilance Division, Medicines for Human Use Department, Spanish Agency for Medicines and Medical Devices (AEMPS), Calle Campezo 1, 28022 Madrid, Spain. Electronic address: pgarciap@aemps.es.
  • de Burgos A; Pharmacoepidemiology and Pharmacovigilance Division, Medicines for Human Use Department, Spanish Agency for Medicines and Medical Devices (AEMPS), Calle Campezo 1, 28022 Madrid, Spain. Electronic address: aburgos_externo@aemps.es.
  • Martínez-González M; Pharmacoepidemiology and Pharmacovigilance Division, Medicines for Human Use Department, Spanish Agency for Medicines and Medical Devices (AEMPS), Calle Campezo 1, 28022 Madrid, Spain. Electronic address: mmartinezgon@aemps.es.
  • Bryant V; Pharmacoepidemiology and Pharmacovigilance Division, Medicines for Human Use Department, Spanish Agency for Medicines and Medical Devices (AEMPS), Calle Campezo 1, 28022 Madrid, Spain. Electronic address: veronica.bryant@gmail.com.
  • Villalobos F; Unitat de Suport a la Recerca Tarragona-Reus, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 43202 Reus, Spain. Electronic address: fvillalobos@idiapjgol.info.
  • Pallejà-Millán M; Unitat de Suport a la Recerca Tarragona-Reus, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 43202 Reus, Spain. Electronic address: mpalleja@idiapjgol.info.
  • Aragón M; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, Spain. Electronic address: maragon@idiapjgol.info.
  • Carreras JJ; Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain. Electronic address: Juanjo.Carreras@fisabio.es.
  • Souverein P; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, PO BOX 80082, 3508 TB Utrecht, the Netherlands. Electronic address: P.C.Souverein@uu.nl.
  • Thurin NH; INSERM CIC-P1401, Bordeaux PharmacoEpi, Univ. Bordeaux, 146 rue Léo Saignat, 33076 Bordeaux cedex, France. Electronic address: nicolas.thurin@u-bordeaux.fr.
  • Weibel D; Department of Datascience & Biostatistics, University Medical Center Utrecht, Heidelberglaan 100, the Netherlands. Electronic address: d.m.weibel@umcutrecht.nl.
  • Klungel OH; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, PO BOX 80082, 3508 TB Utrecht, the Netherlands. Electronic address: o.h.klungel@uu.nl.
  • Sturkenboom M; Department of Datascience & Biostatistics, University Medical Center Utrecht, Heidelberglaan 100, the Netherlands. Electronic address: M.c.j.sturkenboom@umcutrecht.nl.
Vaccine ; 41(1): 251-262, 2023 01 04.
Article en En | MEDLINE | ID: mdl-36446653
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trombocitopenia / Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trombocitopenia / Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article